GL1X · GenesisL1 explorer

MolNFT v1 · #113349 · protein

Vim-2-nat, discovery of novel inhibitor scaffolds against the metallo-beta-lactamase vim-2 by spr based fragment screening

5ACU: “Vim-2-nat, discovery of novel inhibitor scaffolds against the metallo-beta-lactamase vim-2 by spr based…”. X-ray diffraction, 3 ligands (ZN, CL, OH), 1 pocket (best druggability 0.50). MolNFT v1 #113349 on GenesisL1: 3D structure…

PDB
5ACU
Type
protein
Length
230 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
Q9K2N0
Ligands
ZN, CL, OH
Pockets
1 · best druggability 0.50

Structure

x-ray diffraction · 1 distinct chain · 26% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein23026% helix, 27% strandQ9K2N0

Ligands and binding sites

  • ZN · Zinc ion · metal · 3 copies · chains A
  • CL · Chloride ion · ion · 2 copies · chains A
  • OH · Hydroxide ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11240.500.8018OH, ZN

Compared structures

  • 5ACU · VIM-2-NAT, Discovery of novel inhibitor scaffolds against the metallo- beta-lactamase… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.